Adipotide 10 x 5mg

Adipotide — Experimental Research Peptide

Adipotide, also known as FTPP (fat-targeted proapoptotic peptide), is an experimental peptide that has been investigated for its ability to target blood vessels associated with white adipose tissue.

Unlike GLP-1–based compounds, adipotide has been researched through a very different mechanism. Preclinical studies have explored whether it can bind to receptors on the vasculature supplying adipose tissue and trigger apoptotic pathways, potentially altering the blood supply to fat tissue.

🔬 Research Areas

• Adipose-tissue biology — investigated in experimental models of white adipose tissue
• Adipose vasculature — designed to target blood vessels supplying adipose tissue
• Apoptosis research — studied for activation of programmed-cell-death pathways in targeted vascular cells
• Body-composition research — animal studies have examined changes in adiposity and body weight
• Metabolic research — investigated in relation to metabolic changes accompanying alterations in adipose tissue
• Targeted peptide delivery — of interest as an experimental example of receptor-targeted peptide technology

Important Research Context

Evidence for adipotide is predominantly preclinical, including animal research. It is not an established weight-loss medicine, and experimental research has also raised safety concerns, including potential kidney toxicity. Results from animal studies should not be assumed to apply to humans.

⚠️ RESEARCH USE ONLY

Adipotide supplied as a research compound is intended strictly for laboratory and scientific research and is not intended for human or veterinary use. Precision Optimisation does not provide dosing instructions, medical advice or recommendations for personal use.

References to fat tissue, body composition or weight describe areas of experimental investigation and are not claims that adipotide is safe or effective for human weight loss.

PRECISION OPTIMISATION
Explore • Research • Optimise